News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
732,714 Results
Type
Article (44619)
Company Profile (311)
Press Release (687783)
Multimedia
Podcasts (108)
Webinars (16)
Section
Business (212505)
Career Advice (2188)
Deals (37139)
Drug Delivery (116)
Drug Development (84340)
Employer Resources (177)
FDA (16803)
Job Trends (15618)
News (360362)
Policy (34524)
Tag
Academia (2634)
Accelerated approval (11)
Adcomms (29)
Allergies (102)
Alliances (52219)
ALS (115)
Alzheimer's disease (1481)
Antibody-drug conjugate (ADC) (174)
Approvals (16783)
Artificial intelligence (341)
Autoimmune disease (34)
Automation (19)
Bankruptcy (378)
Best Places to Work (11842)
BIOSECURE Act (21)
Biosimilars (135)
Biotechnology (193)
Bladder cancer (94)
Brain cancer (38)
Breast cancer (375)
Cancer (2979)
Cardiovascular disease (234)
Career advice (1826)
Career pathing (33)
CAR-T (194)
CDC (34)
Cell therapy (521)
Cervical cancer (22)
Clinical research (69385)
Collaboration (1073)
Company closure (3)
Compensation (710)
Complete response letters (32)
COVID-19 (2722)
CRISPR (65)
C-suite (342)
Cystic fibrosis (117)
Data (3052)
Decentralized trials (2)
Denatured (33)
Depression (67)
Diabetes (362)
Diagnostics (6544)
Digital health (23)
Diversity (10)
Diversity, equity & inclusion (46)
Drug discovery (147)
Drug pricing (146)
Drug shortages (34)
Duchenne muscular dystrophy (133)
Earnings (89637)
Editorial (44)
Employer branding (21)
Employer resources (154)
Events (117899)
Executive appointments (876)
FDA (18501)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (961)
Gene editing (143)
Generative AI (28)
Gene therapy (402)
GLP-1 (880)
Government (4709)
Grass and pollen (5)
Guidances (182)
Healthcare (19174)
HIV (41)
Huntington's disease (31)
IgA nephropathy (43)
Immunology and inflammation (169)
Immuno-oncology (11)
Indications (40)
Infectious disease (2906)
Inflammatory bowel disease (155)
Inflation Reduction Act (10)
Influenza (62)
Intellectual property (122)
Interviews (341)
IPO (17033)
IRA (53)
Job creations (4170)
Job search strategy (1557)
Kidney cancer (14)
Labor market (53)
Layoffs (543)
Leadership (25)
Legal (8554)
Liver cancer (80)
Longevity (12)
Lung cancer (417)
Lymphoma (213)
Machine learning (11)
Management (61)
Manufacturing (422)
MASH (96)
Medical device (13602)
Medtech (13607)
Mergers & acquisitions (20834)
Metabolic disorders (927)
Multiple sclerosis (102)
NASH (20)
Neurodegenerative disease (129)
Neuropsychiatric disorders (38)
Neuroscience (2201)
NextGen: Class of 2025 (6731)
Non-profit (4564)
Now hiring (48)
Obesity (480)
Opinion (263)
Ovarian cancer (103)
Pain (121)
Pancreatic cancer (122)
Parkinson's disease (194)
Partnered (22)
Patents (314)
Patient recruitment (171)
Peanut (54)
People (60230)
Pharmaceutical (98)
Pharmacy benefit managers (25)
Phase I (21625)
Phase II (30485)
Phase III (22816)
Pipeline (1685)
Policy (230)
Postmarket research (2685)
Preclinical (9160)
Press Release (68)
Prostate cancer (145)
Psychedelics (38)
Radiopharmaceuticals (263)
Rare diseases (498)
Real estate (6377)
Recruiting (68)
Regulatory (23876)
Reports (50)
Research institute (2399)
Resumes & cover letters (371)
Rett syndrome (9)
RNA editing (9)
RSV (56)
Schizophrenia (95)
Series A (163)
Series B (112)
Service/supplier (14)
Sickle cell disease (64)
Special edition (21)
Spinal muscular atrophy (154)
Sponsored (33)
Startups (3807)
State (2)
Stomach cancer (16)
Supply chain (82)
Tariffs (66)
The Weekly (73)
Vaccines (820)
Venture capital (55)
Weight loss (315)
Women's health (48)
Worklife (17)
Date
Today (86)
Last 7 days (357)
Last 30 days (1854)
Last 365 days (32023)
2025 (17403)
2024 (36149)
2023 (40930)
2022 (52113)
2021 (56674)
2020 (55108)
2019 (47821)
2018 (36139)
2017 (33570)
2016 (33170)
2015 (39008)
2014 (32961)
2013 (28077)
2012 (30166)
2011 (30871)
2010 (28889)
Location
Africa (811)
Alabama (62)
Alaska (7)
Arizona (253)
Arkansas (14)
Asia (42117)
Australia (6675)
California (7529)
Canada (2391)
China (709)
Colorado (325)
Connecticut (322)
Delaware (197)
Europe (90405)
Florida (1145)
Georgia (248)
Hawaii (1)
Idaho (59)
Illinois (660)
India (28)
Indiana (376)
Iowa (17)
Japan (238)
Kansas (109)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1049)
Massachusetts (5639)
Michigan (248)
Minnesota (457)
Mississippi (3)
Missouri (90)
Montana (28)
Nebraska (25)
Nevada (82)
New Hampshire (66)
New Jersey (2119)
New Mexico (31)
New York (2112)
North Carolina (1139)
North Dakota (8)
Northern California (3302)
Ohio (240)
Oklahoma (16)
Oregon (40)
Pennsylvania (1630)
Puerto Rico (18)
Rhode Island (36)
South America (1186)
South Carolina (35)
South Dakota (1)
Southern California (2815)
Tennessee (127)
Texas (1145)
United States (28099)
Utah (224)
Virginia (199)
Washington D.C. (73)
Washington State (645)
West Virginia (4)
Wisconsin (69)
732,714 Results for "cocrystal pharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cocrystal Pharma’s Novel Norovirus Antiviral to be Presented at Department of Defense Medical Conference
June 5, 2025
·
5 min read
Press Releases
Cocrystal Pharma to Participate in Noble Capital Markets’ 2025 Emerging Growth Virtual Equity Conference
May 28, 2025
·
1 min read
Press Releases
Cocrystal Pharma to Present Data from Phase 1 Study of First-in-Class Norovirus Protease Inhibitor CDI-988 at the 9th International Calicivirus Conference
July 10, 2025
·
5 min read
Press Releases
Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference
April 16, 2025
·
1 min read
Press Releases
Cocrystal Pharma’s Norovirus Oral Antiviral Candidate Demonstrates Potent Activity Against the Emerging GII.17 Variants
April 25, 2025
·
6 min read
Press Releases
Cocrystal Pharma’s Investigational Drug Candidate CC-42344 Demonstrates Strong Antiviral Potency Against the 2024 Highly Pathogenic H5N1 Avian Influenza Strain
May 29, 2025
·
5 min read
Press Releases
Cocrystal Pharma Reports First Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
May 15, 2025
·
13 min read
Press Releases
Cocrystal Pharma Reports 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
April 1, 2025
·
12 min read
Press Releases
Cocrystal Pharma to Participate in a Fireside Chat at the Zacks SCR Life Sciences Virtual Investor Forum on March 13, 2025
March 6, 2025
·
1 min read
Business
Cocrystal Pharma Reports First Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the three months ended March 31, 2024, and provides updates on its antiviral product pipeline, upcoming milestones and business activities.
May 13, 2024
·
13 min read
1 of 73,272
Next
